411 related articles for article (PubMed ID: 30385172)
41. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
Robnett TJ; Machtay M; Vines EF; McKenna MG; Algazy KM; McKenna WG
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):89-94. PubMed ID: 10924976
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a prognostic nomogram for elderly patients with limited-stage small cell lung cancer receiving radiotherapy.
Zhang L; Zhang Q; Wu Q; Zhao L; Gao Y; Li X; Guan S; Yan M
Sci Rep; 2024 May; 14(1):11990. PubMed ID: 38796503
[TBL] [Abstract][Full Text] [Related]
43. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.
Palma DA; Senan S; Tsujino K; Barriger RB; Rengan R; Moreno M; Bradley JD; Kim TH; Ramella S; Marks LB; De Petris L; Stitt L; Rodrigues G
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):444-50. PubMed ID: 22682812
[TBL] [Abstract][Full Text] [Related]
44. Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.
Wang D; Shi J; Liang S; Lu S; Qi X; Wang Q; Zheng G; Wang S; Zhang K; Liu H
Clin Transl Oncol; 2013 May; 15(5):364-9. PubMed ID: 22975900
[TBL] [Abstract][Full Text] [Related]
45. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
[TBL] [Abstract][Full Text] [Related]
46. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
Wijsman R; Dankers FJWM; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):434-441. PubMed ID: 28871994
[TBL] [Abstract][Full Text] [Related]
47. Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications?
Lan F; Jeudy J; Senan S; van Sornsen de Koste JR; D'Souza W; Tseng HH; Zhou J; Zhang H
Med Phys; 2016 Sep; 43(9):5072. PubMed ID: 27587037
[TBL] [Abstract][Full Text] [Related]
48. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
[TBL] [Abstract][Full Text] [Related]
49. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
Jin H; Tucker SL; Liu HH; Wei X; Yom SS; Wang S; Komaki R; Chen Y; Martel MK; Mohan R; Cox JD; Liao Z
Radiother Oncol; 2009 Jun; 91(3):427-32. PubMed ID: 18937989
[TBL] [Abstract][Full Text] [Related]
50. Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study.
Jang JY; Kim SS; Song SY; Kim YJ; Kim SW; Choi EK
Radiat Oncol; 2021 Dec; 16(1):231. PubMed ID: 34863244
[TBL] [Abstract][Full Text] [Related]
51. Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy.
Weiß A; Löck S; Xu T; Liao Z; Hoffmann AL; Troost EGC
Radiother Oncol; 2024 Jan; 190():110013. PubMed ID: 37972734
[TBL] [Abstract][Full Text] [Related]
52. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
[TBL] [Abstract][Full Text] [Related]
53. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).
Graham MV; Purdy JA; Emami B; Harms W; Bosch W; Lockett MA; Perez CA
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):323-9. PubMed ID: 10487552
[TBL] [Abstract][Full Text] [Related]
54. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
55. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART).
Jenkins P; D'Amico K; Benstead K; Elyan S
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):360-6. PubMed ID: 12738310
[TBL] [Abstract][Full Text] [Related]
56. Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy.
Chen F; Gong X; Zhang K; Yu Y; You T; Hua Y; Dai C; Hu J
Am J Clin Oncol; 2024 Jul; 47(7):317-324. PubMed ID: 38488761
[TBL] [Abstract][Full Text] [Related]
57. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
58. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
[TBL] [Abstract][Full Text] [Related]
59. Radiomics and Dosiomics Signature From Whole Lung Predicts Radiation Pneumonitis: A Model Development Study With Prospective External Validation and Decision-curve Analysis.
Zhang Z; Wang Z; Yan M; Yu J; Dekker A; Zhao L; Wee L
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):746-758. PubMed ID: 36031028
[TBL] [Abstract][Full Text] [Related]
60. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.
Adachi T; Nakamura M; Shintani T; Mitsuyoshi T; Kakino R; Ogata T; Ono T; Tanabe H; Kokubo M; Sakamoto T; Matsuo Y; Mizowaki T
Med Phys; 2021 Apr; 48(4):1781-1791. PubMed ID: 33576510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
